发明名称 |
Aptamer against midkine and applications thereof |
摘要 |
The present invention provides an aptamer binding to midkine and capable of forming a potential secondary structure represented by the formula (I):;
wherein
X1, X2, X5 and X6 are the same or different and each is one or two nucleotides selected from the group consisting of A, G, C, U and T, or a bond,
X1 and X6, and X2 and X5 each form a Watson-Crick base pairs, and
X3 and X4 are the same or different and each is a nucleotide selected from A, G, C, U and T. |
申请公布号 |
US9506070(B2) |
申请公布日期 |
2016.11.29 |
申请号 |
US201314646104 |
申请日期 |
2013.11.21 |
申请人 |
RIBOMIC INC.;OTSUKA PHARMACEUTICAL CO., LTD. |
发明人 |
Miyakawa Shin;Fujiwara Masatoshi;Nakamura Yoshikazu;Kadomatsu Kenji;Mu Ping |
分类号 |
C07H21/02;C07H21/04;C12N15/115;A61K47/48;A61K31/7088;A61K31/713;A61K31/7105;A61K31/711 |
主分类号 |
C07H21/02 |
代理机构 |
Wenderoth, Lind & Ponack, L.L.P. |
代理人 |
Wenderoth, Lind & Ponack, L.L.P. |
主权项 |
1. An aptamer binding to midkine having a length of not more than 45 nucleotides and capable of forming a potential secondary structure represented by the formula (I): wherein X1, X2, X5 and X6 are the same or different and each is one or two nucleotides selected from the group consisting of A, G, C, U and T, or a bond, X1 and X6, and X2 and X5 each form a Watson-Crick base pairs, and X3 and X4 are the same or different and each is a nucleotide selected from A, G, C, U and T. |
地址 |
Tokyo JP |